Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30.

OBJECTIVE The effects of estrogen may be exerted via the nuclear estrogen receptors (ERs) ERalpha or ERbeta or via the recently proposed transmembrane estrogen receptor G protein-coupled receptor 30 (GPR-30). The purpose of this study was to elucidate the ER specificity for the ameliorating effects of estrogen on arthritis and bone loss in a model of postmenopausal rheumatoid arthritis (RA). METHODS Female DBA/1 mice underwent ovariectomy or sham operation, and type II collagen-induced arthritis was induced. Mice were treated subcutaneously 5 days/week with the specific agonists propylpyrazoletriol (PPT; for ERalpha), diarylpropionitrile (DPN; for ERbeta), G1 (for GPR-30), or with a physiologic dose of estradiol. Clinical arthritis scores were determined continuously. At termination of the study, bone mineral density (BMD) was analyzed, paws were collected for histologic assessment, serum was analyzed for cytokines and markers of bone and cartilage turnover, and bone marrow was subjected to fluorescence-activated cell sorting. RESULTS Treatment with PPT as well as estradiol dramatically decreased the frequency and severity of arthritis. Furthermore, estradiol and PPT treatment resulted in preservation of bone and cartilage, as demonstrated by increased BMD and decreased serum levels of bone resorption markers and cartilage degradation markers, whereas no effect was seen after DPN or G1 treatment. CONCLUSION In a well-established model of postmenopausal RA, ERalpha, but not ERbeta or GPR-30 signaling, was shown to ameliorate the disease and the associated development of osteoporosis. Since long-term treatment with estrogen has been associated with significant side effects, increased knowledge about the mechanisms behind the beneficial effects of estrogen is useful in the search for novel treatments of postmenopausal RA.

[1]  E. Levin.  G protein-coupled receptor 30: estrogen receptor or collaborator? , 2009, Endocrinology.

[2]  B. Olde,et al.  The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice. , 2009, American journal of physiology. Endocrinology and metabolism.

[3]  C. Otto,et al.  G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. , 2008, Endocrinology.

[4]  K. Korach,et al.  Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. , 2008, Clinical immunology.

[5]  M. Kelly,et al.  GPR30 contributes to estrogen-induced thymic atrophy. , 2008, Molecular endocrinology.

[6]  Jing Li,et al.  Effects of estrogen receptor subtype-selective agonists on immune functions in ovariectomized mice. , 2006, International immunopharmacology.

[7]  M. Follettie,et al.  Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: responses to disease induction and therapy with the estrogen receptor-beta selective agonist ERB-041. , 2006, Endocrinology.

[8]  C. Ohlsson,et al.  Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation , 2005, Arthritis research & therapy.

[9]  Eric R. Prossnitz,et al.  A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling , 2005, Science.

[10]  C. Fiedler-Nagy,et al.  Meeting report: Mechanisms of bone loss: Rheumatoid arthritis, periodontal disease and osteoporosis , 1987, Agents and Actions.

[11]  N. Ishimaru,et al.  Development of autoimmune exocrinopathy resembling Sjögren's syndrome in estrogen-deficient mice of healthy background. , 2003, The American journal of pathology.

[12]  J. Frasor,et al.  Response-Specific and Ligand Dose-Dependent Modulation of Estrogen Receptor (ER) α Activity by ERβ in the Uterus , 2003 .

[13]  D. Mellström,et al.  Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. , 2003, The Journal of rheumatology.

[14]  R. Holmdahl,et al.  Genistein as an anti-inflammatory agent , 2003, Inflammation Research.

[15]  D. Mellström,et al.  Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis , 2003, Annals of the rheumatic diseases.

[16]  C. Ohlsson,et al.  Oestrogen receptor specificity in oestradiol‐mediated effects on B lymphopoiesis and immunoglobulin production in male mice , 2003, Immunology.

[17]  K. Dahlman-Wright,et al.  Estrogen Receptor (ER)-β Reduces ERα-Regulated Gene Transcription, Supporting a “Ying Yang” Relationship between ERα and ERβ in Mice , 2003 .

[18]  B. Katzenellenbogen,et al.  Characterization of the Biological Roles of the Estrogen Receptors, ERα and ERβ, in Estrogen Target Tissues in Vivo through the Use of an ERα-Selective Ligand , 2002 .

[19]  K. Dahlman-Wright,et al.  Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. , 2002, The Journal of endocrinology.

[20]  Sundeep Khosla,et al.  Sex steroids and the construction and conservation of the adult skeleton. , 2002, Endocrine reviews.

[21]  S. Mohan,et al.  Two Different Pathways for the Maintenance of Trabecular Bone in Adult Male Mice , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  S. Gabriel,et al.  Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. , 2002, Arthritis and rheumatism.

[23]  R. Holmdahl,et al.  The molecular pathogenesis of collagen-induced arthritis in mice—a model for rheumatoid arthritis , 2002, Ageing Research Reviews.

[24]  R. Baron,et al.  Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. , 2002, Bone.

[25]  B. Katzenellenbogen,et al.  Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. , 2001, Journal of medicinal chemistry.

[26]  R. Holmdahl,et al.  Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage. , 2001, Arthritis and rheumatism.

[27]  S. Windahl,et al.  Female Estrogen Receptor β−/− Mice Are Partially Protected Against Age‐Related Trabecular Bone Loss , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  H. Hagino,et al.  Effects of ovariectomy and estrogen replacement therapy on arthritis and bone mineral density in rats with collagen-induced arthritis. , 2001, Bone.

[29]  B. Katzenellenbogen,et al.  Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. , 2000, Journal of medicinal chemistry.

[30]  S. Adami,et al.  A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. , 2000, The Journal of rheumatology.

[31]  A. Vandenbark,et al.  Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. , 2000, The Journal of clinical investigation.

[32]  J. Gustafsson,et al.  Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G. Haugeberg,et al.  Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. , 2000, Arthritis and rheumatism.

[34]  J. Gustafsson,et al.  Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. , 1999, The Journal of clinical investigation.

[35]  R. Turner.  Mice, Estrogen, and Postmenopausal Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  R. Recker,et al.  The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial. , 1999, Annals of internal medicine.

[37]  R. Holmdahl,et al.  Estrogen-mediated immunosuppression in autoimmune diseases , 1998, Inflammation Research.

[38]  S. Boonen,et al.  Androgens and bone. , 2004, Calcified tissue international.

[39]  K. Medina,et al.  Sex Hormones as Negative Regulators of Lymphopoiesis , 1994, Immunological reviews.

[40]  J. Tobias,et al.  The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats. , 1993, Endocrinology.

[41]  A. Tarkowski,et al.  The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model , 1993, Infection and immunity.

[42]  S. Komiya,et al.  Bone Mineral Density in Rheumatoid Arthritis , 1992 .

[43]  A. Tarkowski,et al.  Histopathological and serological progression of experimental Staphylococcus aureus arthritis , 1992, Infection and immunity.

[44]  G. Verbruggen,et al.  Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. , 1990, The Journal of rheumatology.

[45]  R. Holmdahl,et al.  Oestrogen induced suppression of collagen arthritis. IV: Progesterone alone does not affect the course of arthritis but enhances the oestrogen-mediated therapeutic effect. , 1989, Journal of reproductive immunology.

[46]  L. Aarden,et al.  Functional discrimination between interleukin 6 and interleukin 1 , 1988, European journal of immunology.

[47]  R. Holmdahl,et al.  Oestrogen‐Induced Suppression of Collagen Arthritis , 1987 .

[48]  R. Holmdahl,et al.  Female sex hormones suppress development of collagen-induced arthritis in mice. , 1986, Arthritis and rheumatism.

[49]  L. Klareskog,et al.  Homologous type II collagen induces chronic and progressive arthritis in mice. , 1986, Arthritis and rheumatism.

[50]  M. Ostensen,et al.  Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. , 1983, Scandinavian journal of rheumatology.